Change Path »

Vertex Pharmaceuticals Incorporated shares owned by Change Path

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Change Path from 13F filings

Historical chart of Change Path investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Change Path consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Change Path

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.5M 7.5k 465.08
2024-06-30 $2.0M 4.2k 468.73
2024-03-31 $2.5M 5.5k 454.55
2023-06-30 $1.1M 2.6k 400.00
2023-03-31 $936k 3.0k 315.20
2022-12-31 $809k 2.8k 288.79
2022-09-30 $899k 3.1k 289.53
2022-06-30 $228k 808 282.18
2022-03-31 $219k 839 261.03

More positions owned by Change Path

Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Advisorshares Tr Star Glob Buyw (VEGA)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Microsoft Corporation (MSFT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)

View all positions for Change Path

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
FMR
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
Amundi
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation

View all funds holding Vertex Pharmaceuticals Incorporated